Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04076644 · ClinicalTrials.gov registry record · NA
Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder
A NA study of MDD, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04076644: Completed NA study of MDD, sponsored by University of Missouri-Columbia.
NCT04076644 is a NA study of MDD that has completed, run by University of Missouri-Columbia. The registered enrollment target is 11 participants, below the 207-participant average among 7 other MDD trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04076644, a NA study of MDD, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This an open label study using a FDA-cleared TMS stimulation protocols which will be used to treat patients who have responded or remitted from depression using acute clinical TMS therapy at the University of Missouri-Columbia Neuromodulation Clinic. TMS therapy will be given to subjects at monthly intervals. Depression severity questionnaires will be given monthly to determine if the subjects original response to TMS can be maintained. Subjects will be tapered down from antidepressant medication prior to TMS maintenance treatment. Results will be analyzed to determine the effectiveness and feasibility of maintenance TMS therapies in a clinical setting.
Primary Outcome
The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block, scale is 0-27 with 0=no depression, 27=severe depression
Conditions Studied
Interventions
- DEVICE TMS treatment
Study Locations (1)
Missouri
- University of Missouri Neuromodulation Center - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
What the finished NCT04076644 record still lists
NCT04076644 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 207-participant average among 7 other MDD trials with a reported enrollment target (95% lower).
The record links to 1 condition, with MDD appearing as the primary indexed condition, and to 1 intervention - of which TMS treatment is the first listed.
NCT04076644 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04076644 about?
NCT04076644 is a clinical study titled "Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder". This an open label study using a FDA-cleared TMS stimulation protocols which will be used to treat patients who have responded or remitted from depression using acute clinical TMS therapy at the University of Missouri-Columbia Neuromodulation Clinic. TMS therapy will be given to subjects at monthly ...
What is the current status of trial NCT04076644?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-09-01. Estimated completion is 2021-09-01.
What conditions does trial NCT04076644 study?
This clinical trial studies the following conditions: MDD.
What interventions are being tested in trial NCT04076644?
The interventions under investigation include: TMS treatment (DEVICE).
Who is sponsoring clinical trial NCT04076644?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04076644 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for MDD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RECRUITING · NA
-
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
RECRUITING · NA
-
Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder
ACTIVE NOT RECRUITING · NA
-
Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study.
COMPLETED · NA
-
Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder
COMPLETED · NA
-
Mechanism of Action of tACS for the Treatment of MDD
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI